Helpline
+91 8892 555 000
Email : contactus@ordindia.in

Rare disease treatment: Rs 100-crore fund not set up despite earlier claim, Centre tells Delhi HC

The Centre has told the Delhi High Court that it did not allocate an initial corpus for treatment of life-threatening diseases under the National Policy on Treatment of Rare Diseases...

Read More

Centre takes u-turn on setting up of Rs 100 crore fund to treat rare diseases

A year after first announcing that a special fund of Rs 100 crore was being set up to help children suffering from rare diseases, the Centre has now taken a...

Read More

No fund allotted to treat rare diseases despite claim in court: Centre

A petition on behalf of families of patients of rare diseases has sought government aid for treatment. It states that the ESI has the obligation not only under the Employees’...

Read More

‘Handigodu’ patients to appeal for mercy killing

  Online Link...

Read More

Gov’t to reduce burden for rare disease patients

By Jung Hae-myoung Starting next year, more patients battling rare diseases will pay less for their medical expenses, as 100 disorders have been newly added to the government’s subsidy list,...

Read More

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Farber disease is a rare, autosomal-recessive disorder caused by a mutation in the acid ceramidase gene, which leads to accumulation of sphingolipids in various tissues.1 It typically presents with a combination...

Read More

Why the birth of first gene-edited babies in China has got the whole world worried and alarmed

Chinese scientist He Jiankui speaks at the Second International Summit on Human Genome Editing in Hong Kong on November 28, 2018. The announcement of the birth of babies with edited...

Read More

Kids die of rare diseases, as govt struggles fund shortage

The ministry of health and family welfare that is getting continuous requests from patient organizations for funds has reached out to the finance ministry seeking financial help. New Delhi: Several...

Read More

A rare-disease entrepreneur follows an unconventional drug development path

In 2012, Ethan Perlstein challenged the academic status quo. Now as CEO of the start-up Perlara, can he do the same for the biotech industry? In 2012, molecular biologist Ethan...

Read More

A comparative study of orphan drugs in US, EU & India

Today, more than 5,000 diseases are catalogued as “rare” by the scientific community, so long as they affect small sections of population. The drugs used for the treatment of rare...

Read More

Upcoming Events

Our Executive Director Mr. Prasanna Shirol was a part of First Ever summit dedicated to advancing equitable care for rare diseases in older adults. The meeting was attended from 25 countries across Canada, Latin America, Europe, and Asia, representing patient and caregiver communities, patient advocates, healthcare professionals, and healthcare policy experts. This is a short video highlighting the impact of the initiative to date, in the words of the COLLABORATE Community.

Highslide for Wordpress Plugin